Business Development & Market Access

The Business Development & Market Access team at Hansa Biopharma is responsible for identifying strategic partnerships, advancing corporate alliances, and ensuring market accessibility for the company's innovative immunomodulating therapies. They work to expand market reach, negotiate commercialization deals, and facilitate access to treatments for patients across global markets, thereby supporting Hansa’s mission to deliver lifesaving therapies for rare autoimmune conditions, transplant rejection, and cancer.